Symmetry Investments’s Lux Health Tech Acquisition Corp. Class A Common Stock LUXA Stock Holding History

Symmetry Investments’s Portfolio LUXA Stock Details LUXA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-122,946	Closed	-$1.21M	–	143
2022 Q1	$1.21M	Hold	122,946	–	–	0.18%	69
2021 Q4	$1.21M	Buy	122,946 +25,000	+26%	+$246K	0.37%	58
2021 Q3	$961K	Sell	97,946 -176,383	-64%	-$1.74M	0.15%	96
2021 Q2	$2.71M	Buy	274,329 +24,329	+10%	+$245K	0.77%	33
2021 Q1	$2.57M	Buy	+250,000	New	+$2.78M	0.62%	43

Other funds holding LUXA

ECP

Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

Wolfswood Holdings New York $2.84M AUM 30.46% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

Symmetry Investments's LUXA Position: Q2 2022 in Review

Symmetry Investments sold out of Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) in Q2 2022, closing a stake of 122,946 shares — an estimated $1.21M sold.

Symmetry Investments first reported a position in LUXA in Q1 2021 and held it in 5 quarters. The position peaked at $2.71M in Q2 2021. 71 funds tracked by Wall St. Rank hold LUXA as of Q2 2022.

Symmetry Investments reported no remaining Lux Health Tech Acquisition Corp. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
Symmetry Investments sold 122,946 Lux Health Tech Acquisition Corp. Class A Common Stock shares in Q2 2022, an estimated $1.21M.
Symmetry Investments first reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock in Q1 2021 and held it in 5 quarters.
Symmetry Investments's Lux Health Tech Acquisition Corp. Class A Common Stock position peaked at $2.71M in Q2 2021.
71 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Class A Common Stock as of Q2 2022.

Based on Symmetry Investments's 13F filing for Q2 2022, filed 26 Jul 2022.